These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 21693124)
1. Presence of bioactive lysophosphatidic acid in renal effluent of rats with unilateral ureteral obstruction. Tsutsumi T; Adachi M; Nikawadori M; Morishige J; Tokumura A Life Sci; 2011 Aug; 89(5-6):195-203. PubMed ID: 21693124 [TBL] [Abstract][Full Text] [Related]
2. Urinary concentration and tissue messenger RNA expression of monocyte chemoattractant protein-1 as an indicator of the degree of hydronephrotic atrophy in partial ureteral obstruction. Stephan M; Conrad S; Eggert T; Heuer R; Fernandez S; Huland H J Urol; 2002 Mar; 167(3):1497-502. PubMed ID: 11832777 [TBL] [Abstract][Full Text] [Related]
3. Altered activity of lysophospholipase D, which produces bioactive lysophosphatidic acid and choline, in serum from women with pathological pregnancy. Tokumura A; Kume T; Taira S; Yasuda K; Kanzaki H Mol Hum Reprod; 2009 May; 15(5):301-10. PubMed ID: 19297419 [TBL] [Abstract][Full Text] [Related]
4. [Effects of reduced glutathione on contents of hydroxyproline and oxidation stress reaction in kidney of unilateral ureteral obstruction in rat]. Na Y; Zhang XX; Zhang XD; Yuan HP; Hu XL; Zheng W; Li G Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Dec; 19(12):735-8. PubMed ID: 18093431 [TBL] [Abstract][Full Text] [Related]
5. Early induction of osteoactivin expression in rat renal tubular epithelial cells after unilateral ureteral obstruction. Nakamura A; Ishii A; Ohata C; Komurasaki T Exp Toxicol Pathol; 2007 Sep; 59(1):53-9. PubMed ID: 17588730 [TBL] [Abstract][Full Text] [Related]
6. Unilateral ureteral obstruction alters expression of acid-base transporters in rat kidney. Wang G; Ring T; Li C; Kim SW; Wen J; Djurhuus JC; Nielsen S; Frøkiaer J J Urol; 2009 Dec; 182(6):2964-73. PubMed ID: 19846141 [TBL] [Abstract][Full Text] [Related]
7. Increased production of bioactive lysophosphatidic acid by serum lysophospholipase D in human pregnancy. Tokumura A; Kanaya Y; Miyake M; Yamano S; Irahara M; Fukuzawa K Biol Reprod; 2002 Nov; 67(5):1386-92. PubMed ID: 12390867 [TBL] [Abstract][Full Text] [Related]
8. The potential protective role of lysophospholipid mediators in nephrotoxicity induced by chronically exposed cadmium. Tsutsumi T; Ishihara A; Yamamoto A; Asaji H; Yamakawa S; Tokumura A Food Chem Toxicol; 2014 Mar; 65():52-62. PubMed ID: 24361405 [TBL] [Abstract][Full Text] [Related]
9. Alterations of plasma levels of lysophosphatidic acid in response to fasting of rats. Ino M; Shimizu Y; Tanaka T; Tokumura A Biol Pharm Bull; 2012; 35(11):2059-63. PubMed ID: 23123475 [TBL] [Abstract][Full Text] [Related]
10. Lysophospholipids and lysophospholipase D in rabbit aqueous humor following corneal injury. Tokumura A; Taira S; Kikuchi M; Tsutsumi T; Shimizu Y; Watsky MA Prostaglandins Other Lipid Mediat; 2012 Mar; 97(3-4):83-9. PubMed ID: 22281604 [TBL] [Abstract][Full Text] [Related]
11. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats]. Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283 [TBL] [Abstract][Full Text] [Related]
12. Increased Levels of Renal Lysophosphatidic Acid in Rodent Models with Renal Disease. Hirata T; Smith SV; Takahashi T; Miyata N; Roman RJ J Pharmacol Exp Ther; 2021 Feb; 376(2):240-249. PubMed ID: 33277348 [TBL] [Abstract][Full Text] [Related]
13. Bone marrow mononuclear cells shift bioactive lipid pattern in injured kidney towards tissue repair in rats with unilateral ureteral obstruction. Verdoorn KS; Lindoso RS; Lowe J; Lara LS; Vieyra A; Einicker-Lamas M Nephrol Dial Transplant; 2010 Dec; 25(12):3867-74. PubMed ID: 20504839 [TBL] [Abstract][Full Text] [Related]
14. Altered plasma levels of lysophospholipids in response to adrenalectomy of rats. Tsutsumi T; Ino M; Shimizu Y; Kawabata K; Nishi H; Tokumura A Prostaglandins Other Lipid Mediat; 2021 Oct; 156():106579. PubMed ID: 34245896 [TBL] [Abstract][Full Text] [Related]
15. Lysophospholipids in the limelight: autotaxin takes center stage. Moolenaar WH J Cell Biol; 2002 Jul; 158(2):197-9. PubMed ID: 12135981 [TBL] [Abstract][Full Text] [Related]
16. PAX2 re-expression in renal tubular epithelial cells and correlation with renal interstitial fibrosis of rats with obstructive nephropathy. Li L; Wu Y; Zhang W Ren Fail; 2010 Jun; 32(5):603-11. PubMed ID: 20486844 [TBL] [Abstract][Full Text] [Related]
17. Extracellular and intracellular productions of lysophosphatidic acids and cyclic phosphatidic acids by lysophospholipase D from exogenously added lysophosphatidylcholines to cultured NRK52E cells. Tsutsumi T; Kawabata K; Yamazaki N; Tsukigawa K; Nishi H; Tokumura A Biochim Biophys Acta Mol Cell Biol Lipids; 2023 Sep; 1868(9):159349. PubMed ID: 37295607 [TBL] [Abstract][Full Text] [Related]
18. Does cyclooxygenase-2 inhibitor prevent renal tissue damage in unilateral ureteral obstruction? Miyajima A; Ito K; Asano T; Seta K; Ueda A; Hayakawa M J Urol; 2001 Sep; 166(3):1124-9. PubMed ID: 11490310 [TBL] [Abstract][Full Text] [Related]
19. Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases. Fitzgerald JP; Chou SY; Franco I; Mooppan UM; Kim H; Saini R; Gulmi FA J Urol; 2009 Oct; 182(4 Suppl):1860-8. PubMed ID: 19692013 [TBL] [Abstract][Full Text] [Related]